Stay updated on Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial

Sign up to get notified when there's something new on the Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision history updated to v3.5.0 and v3.4.3 was removed from the records.
    Difference
    0.1%
    Check dated 2026-03-18T18:04:04.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The study history now shows the latest revision as v3.4.3, replacing v3.4.2. This change is limited to version labeling and does not modify the study's content or behavior.
    Difference
    0.1%
    Check dated 2026-03-11T14:12:34.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the record history, and the prior funding-status notice and revision v3.4.1 were removed.
    Difference
    0.7%
    Check dated 2026-02-11T01:39:27.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A general notice about government funding and the NIH Clinical Center’s operating status has been added to the page. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.7%
    Check dated 2026-02-03T23:45:46.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The history view now includes a glossary toggle and green/red color-coded highlights to distinguish additions and deletions. Footer notes were updated to show Revision: v3.4.0, with the previous No FEAR Act text and revision (v3.3.4) replaced.
    Difference
    0.9%
    Check dated 2026-01-27T22:08:58.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T08:20:07.000Z thumbnail image

Stay in the know with updates to Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial page.